MedKoo Cat#: 129051 | Name: ARM-165

Description:

WARNING: This product is for research use only, not for human or veterinary use.

ARM-165 is a PI3K PROTAC degrader.

Chemical Structure

ARM-165
ARM-165
CAS#N/A

Theoretical Analysis

MedKoo Cat#: 129051

Name: ARM-165

CAS#: N/A

Chemical Formula: C44H51N7O8S

Exact Mass: 837.3500

Molecular Weight: 837.99

Elemental Analysis: C, 63.07; H, 6.13; N, 11.70; O, 15.27; S, 3.83

Price and Availability

Related CAS #
No Data
Synonym
ARM-165; ARM165; ARM 165
IUPAC/Chemical Name
N1-(5-(2-((S)-1-cyclopropylethyl)-7-methyl-1-oxoisoindolin-5-yl)-4-methylthiazol-2-yl)-N5-(8-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)-8-oxooctyl)glutaramide
InChi Key
HPQOLTMYIUOBAP-RNWYOQHESA-N
InChi Code
InChI=1S/C44H51N7O8S/c1-24-21-28(22-29-23-50(42(58)37(24)29)26(3)27-16-17-27)39-25(2)46-44(60-39)49-35(54)15-10-14-33(52)45-20-8-6-4-5-7-13-34(53)47-31-12-9-11-30-38(31)43(59)51(41(30)57)32-18-19-36(55)48-40(32)56/h9,11-12,21-22,26-27,32H,4-8,10,13-20,23H2,1-3H3,(H,45,52)(H,47,53)(H,46,49,54)(H,48,55,56)/t26-,32?/m0/s1
SMILES Code
CC1=C2C(N(CC2=CC(C3=C(N=C(S3)NC(CCCC(NCCCCCCCC(NC4=CC=CC5=C4C(N(C5=O)C6CCC(NC6=O)=O)=O)=O)=O)=O)C)=C1)[C@H](C7CC7)C)=O
Appearance
To be determined
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 -4 C for short term (days to weeks) or -20 C for long term(months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info
Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 837.99 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Kelly LM, Rutter JC, Lin KH, Ling F, Duchmann M, Latour E, Arang N, Pasquer H, Ho Nhat D, Charles J, Killarney ST, Ang HX, Namor F, Culeux C, Lombard B, Loew D, Swaney DL, Krogan NJ, Brunel L, Carretero É, Verdié P, Amblard M, Fodil S, Huynh T, Sebert M, Adès L, Raffoux E, Fenouille N, Itzykson R, Lobry C, Benajiba L, Forget A, Martin AR, Wood KC, Puissant A. Targeting a lineage-specific PI3Kɣ-Akt signaling module in acute myeloid leukemia using a heterobifunctional degrader molecule. Nat Cancer. 2024 Jul;5(7):1082-1101. doi: 10.1038/s43018-024-00782-5. Epub 2024 May 30. PMID: 38816660; PMCID: PMC11778622.